AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS
Key Development
In July 2019, Progentec Diagnostics, Inc. merged with Karate Health, Inc, to offer laboratory testing and digital technologies for the diagnosis and management of autoimmune diseases.
In March, 2019 Eli Lilly collaborated with ImmuNext to study and develop a preclinical novel potential target for autoimmune disease treatments.
In January 2019, Vital Therapies, Inc., and Immunic AG entered into a definitive agreement in which Vital Therapies, Inc. focused on Immunic‘s pipeline of novel and potentially transformative treatments for chronic inflammatory and autoimmune diseases.
In 2018, Quidel Corporation, received CE mark for its Sofia Quantitative Vitamin D FIA for use with Sofia fluorescent immunoassay analyzer.
In 2017, ImmunArray and Kindstar Global Co., Ltd., announced a partnership and introduced ImmunArray’s lupus rule-out test in China.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
